Janux Therapeutics, Inc. (JANX)

NASDAQ: JANX · IEX Real-Time Price · USD
13.04
+0.56 (4.49%)
Jul 6, 2022 4:00 PM EDT - Market closed

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Cash & Equivalents
36.47.810.66
Short-Term Investments
339.3800
Cash & Cash Equivalents
375.787.810.66
Cash Growth
4709.69%1087.39%-
Receivables
080
Other Current Assets
1.240.250
Total Current Assets
377.0216.060.66
Property, Plant & Equipment
1.60.160.02
Other Long-Term Assets
1.2100
Total Long-Term Assets
2.810.160.02
Total Assets
379.8216.220.68
Accounts Payable
2.460.430.27
Deferred Revenue
5.8680
Current Debt
0.1904
Other Current Liabilities
4.28-5.250.36
Total Current Liabilities
12.83.184.63
Other Long-Term Liabilities
0.76.05-
Total Long-Term Liabilities
0.76.050
Total Liabilities
13.59.234.63
Total Debt
0.1904
Common Stock
414.010.10.01
Retained Earnings
-47.41-14.74-7.96
Comprehensive Income
-0.2700
Shareholders' Equity
366.33-14.64-7.94
Total Liabilities and Equity
379.82-5.41-3.32
Net Cash / Debt
375.597.81-3.34
Net Cash / Debt Growth
4707.21%--
Net Cash Per Share
15.968.54-4.99
Working Capital
364.2212.88-3.97
Book Value Per Share
15.57-15.99-11.87
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).